Closing Bell: Best Bull Market Opportunities 9/24/24
Where can investors find the best opportunities in this bull market? Trivariate’s Adam Parker, New York Life Investments’ Lauren Goodwin and Invesco’s Kristina Hooper break down where they are seeing strength right now. Plus, top technician Chris Verrone tells us which parts of the market he thinks are about to break out. And, Novo Nordisk shareholder Michelle Ross of Stempoint Capital gives her first reaction to the Novo Nordisk CEO testifying on Capitol Hill over weight loss drug pricing.
September 24, 2024
43 min
Full
1,377 of 2,295
September 24, 2024
Closing Bell: Best Bull Market Opportunities 9/24/24
0:00 / 43:22
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Cnbc Episodes Around September 24, 2024
Episode 1,377 of 2,295 — walk the feed in the order it was published.
42:44Closing Bell Overtime: Dow, S&P 500 record closes; Rare Microsoft downgrade 9/23/24
43:22This episodeClosing Bell: Best Bull Market Opportunities 9/24/24
Summary
Where can investors find the best opportunities in this bull market? Trivariate’s Adam Parker, New York Life Investments’ Lauren Goodwin and Invesco’s Kristina Hooper break down where they are seeing strength right now. Plus, top technician Chris Verrone tells us which parts of the market he thinks are about to break out. And, Novo Nordisk shareholder Michelle Ross of Stempoint Capital gives her first reaction to the Novo Nordisk CEO testifying on Capitol Hill over weight loss drug pricing.
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.